New eye drops aim to control wet macular degeneration
NCT ID NCT05637255
First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and help maintain or improve vision. Participants received the eye drops and were monitored for changes in eyesight over 42 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SYL1801 Investigative Site
Brno, 62500, Czechia
-
SYL1801 Investigative Site
Chomutov, 43001, Czechia
-
SYL1801 Investigative Site
Frýdek-Místek, 738 01, Czechia
-
SYL1801 Investigative Site
Kyjov, 69701, Czechia
-
SYL1801 Investigative Site
Liberec, 46063, Czechia
-
SYL1801 Investigative Site
Ostrava, 70200, Czechia
-
SYL1801 Investigative Site
Prague, 14000, Czechia
-
SYL1801 Investigative Site
Prague, 17000, Czechia
-
SYL1801 Investigative Site
Gdansk, 80-809, Poland
-
SYL1801 Investigative Site
Krakow, 31-070, Poland
-
SYL1801 Investigative Site
Rzeszów, 35-017, Poland
-
SYL1801 Investigative Site
Warsaw, 01-258, Poland
-
SYL1801 Investigative Site
Bratislava, 85107, Slovakia
-
SYL1801 Investigative Site
Košice, 04011, Slovakia
-
SYL1801 Investigative Site
Poprad, 05801, Slovakia
-
SYL1801 Investigative Site
Žilina, Slovakia
Conditions
Explore the condition pages connected to this study.